CrossRef Cited-by Linking Search Results

This Article:

has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking:

  • The Concentrations of Some Gut Polypeptides Are Elevated During Lactation in Ruminants
    Anne Faulkner and Pamela A Martin
    Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology (1997) 118 :563
  • Plasma concentrations and effects of glucagon-like peptide-1 (7-36) amide in calves before and after weaning
    R. Fukumori, T. Mita, T. Sugino, T. Obitsu, and K. Taniguchi
    Domestic Animal Endocrinology (2012) 43 :299
  • Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes
    W. Alsalim, A. Tura, G. Pacini, B. Omar, R. Bizzotto, A. Mari, and B. Ahrén
    Diabetes, Obesity and Metabolism (2016) 18 :24
  • The functional involvement of gut-expressed sweet taste receptors in glucose-stimulated secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY)
    R.E. Steinert, A.C. Gerspach, H. Gutmann, L. Asarian, J. Drewe, and C. Beglinger
    Clinical Nutrition (2011) 30 :524
  • Glucagonlike peptide 1: A newly discovered gastrointestinal hormone
    Jens Juul Holst
    Gastroenterology (1994) 107 :1848
  • Establishment of new clonal pancreatic β-cell lines (MIN6-K) useful for study of incretin/cyclic adenosine monophosphate signaling
    Masahiro Iwasaki, Kohtaro Minami, Tadao Shibasaki, Takashi Miki, Jun-ichi Miyazaki, and Susumu Seino
    Journal of Diabetes Investigation (2010) :no
  • Protein Digestion-Derived Peptides and the Peripheral Regulation of Food Intake
    Juliette Caron, Dorothée Domenger, Pascal Dhulster, Rozenn Ravallec, and Benoit Cudennec
    Frontiers in Endocrinology (2017) 8 :
  • The gut endocrine system as a coordinator of postprandial nutrient homoeostasis
    Fiona M. Gribble
    Proceedings of the Nutrition Society (2012) 71 :456
  • Targeting the glucagon receptor family for diabetes and obesity therapy
    Young Min Cho, Catherine E. Merchant, and Timothy J. Kieffer
    Pharmacology & Therapeutics (2012) 135 :247
  • Glucose-dependent action of glucagon-like peptide-1(7-37) in vivo during short- or long-term administration
    Diane M. Hargrove, Nancy A. Nardone, Lorna M. Persson, Janice C. Parker, and Ralph W. Stevenson
    Metabolism (1995) 44 :1231
  • Role of TCF7L2 risk variant and dietary fibre intake on incident type 2 diabetes
    G. Hindy, E. Sonestedt, U. Ericson, X.-J. Jing, Y. Zhou, O. Hansson, E. Renström, E. Wirfält, and M. Orho-Melander
    Diabetologia (2012) 55 :2646
  • Glucagon-Like Peptide-1 Secreting Cell Function as well as Production of Inflammatory Reactive Oxygen Species Is Differently Regulated by Glycated Serum and High Levels of Glucose
    Alessandra Puddu, Roberta Sanguineti, Fabrizio Montecucco, and Giorgio L. Viviani
    Mediators of Inflammation (2014) 2014 :1
  • Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus
    Diva D. De León, Michael F. Crutchlow, Jee-Young Nina Ham, and Doris A. Stoffers
    The International Journal of Biochemistry & Cell Biology (2006) 38 :845
  • Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease
    A. Zarrinpar and R. Loomba
    Alimentary Pharmacology & Therapeutics (2012) 36 :909
  • The major glucagon-like peptide-1 metabolite, GLP-1-(9–36)-amide, does not affect glucose or insulin levels in mice
    Bidda Rolin, Carolyn F Deacon, Richard D Carr, and Bo Ahrén
    European Journal of Pharmacology (2004) 494 :283
  • Glucagon-like peptide-1 reduces contractile function and fails to boost glucose utilization in normal hearts in the presence of fatty acids
    T. Dung Nguyen, Yasushige Shingu, Paulo A. Amorim, Michael Schwarzer, and Torsten Doenst
    International Journal of Cardiology (2013) 168 :4085
  • GIP and GLP-1(7–36)amide secretion in response to intraduodenal infusions of nutrients in pigs
    J.M.E. Knapper, A. Heath, J.M. Fletcher, L.M. Morgan, and V. Marks
    Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology (1995) 111 :445
  • Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans
    Qiang Xiao, Robin P. Boushey, Daniel J. Drucker, and Patricia L. Brubaker
    Gastroenterology (1999) 117 :99
  • Nutrient detection by incretin hormone secreting cells
    Eleftheria Diakogiannaki, Fiona M. Gribble, and Frank Reimann
    Physiology & Behavior (2012) 106 :387
  • Dietary sweet potato (Ipomoea batatas L.) leaf extract attenuates hyperglycaemia by enhancing the secretion of glucagon-like peptide-1 (GLP-1)
    Rika Nagamine, Shiori Ueno, Masahito Tsubata, Kazuya Yamaguchi, Kinya Takagaki, Tohru Hira, Hiroshi Hara, and Takanori Tsuda
    Food & Function (2014) 5 :2309
  • Alternative form of glucose-dependent insulinotropic polypepide and its physiology
    Yukihiro Fujita, Tsuyoshi Yanagimachi, Yasutaka Takeda, Jun Honjo, Yumi Takiyama, Atsuko Abiko, Yuichi Makino, and Masakazu Haneda
    Journal of Diabetes Investigation (2016) 7 :33
  • Possible role of PEPT1 in gastrointestinal hormone secretion
    Kimio Matsumura, Takashi Miki, Takahito Jhomori, Tohru Gonoi, and Susumu Seino
    Biochemical and Biophysical Research Communications (2005) 336 :1028
  • Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of BI 1356, an Inhibitor of Dipeptidyl Peptidase 4, in Healthy Male Volunteers
    S. Hüttner, E. U. Graefe-Mody, B. Withopf, A. Ring, and K. A. Dugi
    The Journal of Clinical Pharmacology (2008) 48 :1171
  • Insulin modulates glucose-dependent insulinotropic polypeptide (GIP) secretion from enteroendocrine K cells in rats
    Nigel Irwin, Jacqueline M.E. Francis, and Peter R. Flatt
    Biological Chemistry (2011) 392 :
  • Gut?Brain Axis: Regulation of Glucose Metabolism
    A. C. Heijboer, H. Pijl, A. M. Van den Hoek, L. M. Havekes, J. A. Romijn, and E. P. M. Corssmit
    Journal of Neuroendocrinology (2006) 18 :883
  • The effect of circulating non-esterified fatty acids on the entero-insular axis
    Ranganath, Norris, Morgan, Wright, and Marks
    European Journal of Clinical Investigation (1999) 29 :27
  • Plant-rich mixed meals based on Palaeolithic diet principles have a dramatic impact on incretin, peptide YY and satiety response, but show little effect on glucose and insulin homeostasis: an acute-effects randomised study
    H. Frances J. Bligh, Ian F. Godsland, Gary Frost, Karl J. Hunter, Peter Murray, Katrina MacAulay, Della Hyliands, Duncan C. S. Talbot, John Casey, Theo P. J. Mulder, and Mark J. Berry
    British Journal of Nutrition (2015) 113 :574
  • Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system
    Toshimasa Osaka, Mari Endo, Midori Yamakawa, and Shuji Inoue
    Peptides (2005) 26 :1623
  • Dietary supplementation with hydroxypropyl-distarch phosphate from waxy maize starch increases resting energy expenditure by lowering the postprandial glucose-dependent insulinotropic polypeptide response in human subjects
    Akira Shimotoyodome, Junko Suzuki, Yoji Kameo, and Tadashi Hase
    British Journal of Nutrition (2011) 106 :96
  • Raised FGF-21 and Triglycerides Accompany Increased Energy Intake Driven by Protein Leverage in Lean, Healthy Individuals: A Randomised Trial
    Alison K. Gosby, Namson S. Lau, Charmaine S. Tam, Miguel A. Iglesias, Christopher D. Morrison, Ian D. Caterson, Jennie Brand-Miller, Arthur D. Conigrave, David Raubenheimer, Stephen J. Simpson, and Darcy Johannsen
    PLOS ONE (2016) 11 :e0161003
  • Pharmacokinetics and Pharmacodynamics of Vildagliptin??in??Patients?? with Type??2??Diabetes??Mellitus
    Yan-Ling He, Denise Serra, Yibin Wang, Joelle Campestrini, Gilles-Jacques Riviere, Carolyn F Deacon, Jens J Holst, Sherwyn Schwartz, Jace C Nielsen, and Monica Ligueros-Saylan
    Clinical Pharmacokinetics (2007) 46 :577
  • Circadian Aspects of Postprandial Metabolism
    Linda Morgan, Shelagh Hampton, Michelle Gibbs, and Josephine Arendt
    Chronobiology International (2003) 20 :795
  • Harnessing the gut to treat diabetes
    Yukihiro Fujita, Anthony T. Cheung, and Timothy J. Kieffer
    Pediatric Diabetes (2004) 5 :57
  • Combination treatment with alogliptin and voglibose increases active GLP-1 circulation, prevents the development of diabetes and preserves pancreatic beta-cells in prediabeticdb/dbmice
    Y. Moritoh, K. Takeuchi, and M. Hazama
    Diabetes, Obesity and Metabolism (2010) 12 :224
  • Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness
    Dominique Delmeire, Daisy Flamez, Karen Moens, Simon A Hinke, Chris Van Schravendijk, Daniel Pipeleers, and Frans Schuit
    Biochemical Pharmacology (2004) 68 :33
  • Beneficial metabolic actions of a stable GIP agonist following pre-treatment with a SGLT2 inhibitor in high fat fed diabetic mice
    P.J.B. Millar, V. Pathak, R.C. Moffett, N.M. Pathak, A.J. Bjourson, M.J. O'Kane, P.R. Flatt, and V.A. Gault
    Molecular and Cellular Endocrinology (2016) 420 :37
  • Circadian Secretion of the Intestinal Hormone GLP-1 by the Rodent L Cell
    Manuel Gil-Lozano, Erli L. Mingomataj, W. Kelly Wu, Sean A. Ridout, and Patricia L. Brubaker
    Diabetes (2014) 63 :3674
  • Mechanisms for the cardiovascular effects of glucagon-like peptide-1
    H. Poudyal
    Acta Physiologica (2016) 216 :277
  • Incretin actions and consequences of incretin-based therapies: lessons from complementary animal models
    Simone Renner, Andreas Blutke, Elisabeth Streckel, Rüdiger Wanke, and Eckhard Wolf
    The Journal of Pathology (2016) 238 :345
  • Molecular Mechanisms of Glucose-Stimulated GLP-1 Secretion From Perfused Rat Small Intestine
    Rune E. Kuhre, Charlotte R. Frost, Berit Svendsen, and Jens J. Holst
    Diabetes (2015) 64 :370
  • Nutritional sensing and its utility in treating obesity
    Anjali Amin and Kevin G Murphy
    Expert Review of Endocrinology & Metabolism (2012) 7 :209
  • A Tripeptide Diapin Effectively Lowers Blood Glucose Levels in Male Type 2 Diabetes Mice by Increasing Blood Levels of Insulin and GLP-1
    Jifeng Zhang, Changyong Xue, Tianqing Zhu, Anuradha Vivekanandan, Subramaniam Pennathur, Zhongmin Alex Ma, Y. Eugene Chen, and Tianru Jin
    PLoS ONE (2013) 8 :e83509
  • On the Effects of Glucagon-Like Peptide-1 on Blood Glucose Regulation in Normal and Diabetic Subjects
    Annals of the New York Academy of Sciences (2006) 805 :729
  • G-Protein-Coupled Receptors in Intestinal Chemosensation
    Frank Reimann, Gwen Tolhurst, and Fiona M. Gribble
    Cell Metabolism (2012) 15 :421
  • DPP-4 inhibitors in the treatment of type 2 diabetes
    Hélène Duez, Bertrand Cariou, and Bart Staels
    Biochemical Pharmacology (2012) 83 :823
  • Peripheral Glucagon-like Peptide-1 (GLP-1) and Satiation
    Mukesh Punjabi, Myrtha Arnold, Nori Geary, Wolfgang Langhans, and Gustavo Pacheco-López
    Physiology & Behavior (2011) 105 :71
  • Once-weekly dulaglutide 1.5 mg restores insulin secretion in response to intravenous glucose infusion
    Amparo de la Peña, Corina Loghin, Xuewei Cui, Xin Zhang, Christoph Kapitza, and Ronan P. Kelly
    Diabetes, Obesity and Metabolism (2017) 19 :517
  • Intestinal feedback signaling and satiety
    Timothy H. Moran and Megan J. Dailey
    Physiology & Behavior (2011) 105 :77
  • Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes
    Ann Mosegaard Bak, Lærke Egefjord, Michael Gejl, Charlotte Steffensen, Chalotte Willemann Stecher, Kamille Smidt, Birgitte Brock, and Jørgen Rungby
    Expert Opinion on Therapeutic Targets (2011) 15 :1153
  • The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-l, but not to glucose-dependent insulinotropic polypeptide, in the portal vein
    Makoto Nishizawa, Hajime Nakabayashi, Kenzo Uchida, Atsushi Nakagaw, and Akira Niijima
    Journal of the Autonomic Nervous System (1996) 61 :149
  • Ectopic expression of glucagon-like peptide 1 for gene therapy of type II diabetes
    G B Parsons, D W Souza, H Wu, D Yu, S G Wadsworth, R J Gregory, and D Armentano
    Gene Therapy (2007) 14 :38
  • Ingestion of a moderate high-sucrose diet results in glucose intolerance with reduced liver glucokinase activity and impaired glucagon-like peptide-1 secretion
    Eriko Sakamoto, Yusuke Seino, Ayako Fukami, Naohiro Mizutani, Shin Tsunekawa, Kota Ishikawa, Hidetada Ogata, Eita Uenishi, Hideki Kamiya, Yoji Hamada, Hiroyuki Sato, Norio Harada, Yukiyasu Toyoda, Ichitomo Miwa, Jiro Nakamura, Nobuya Inagaki, Yutaka Oiso, and Nobuaki Ozaki
    Journal of Diabetes Investigation (2012) 3 :432
  • The effect of a high-MUFA, low-glycaemic index diet and a low-fat diet on appetite and glucose metabolism during a 6-month weight maintenance period
    Birgitte Sloth, Anette Due, Thomas M. Larsen, Jens J. Holst, Anders Heding, and Arne Astrup
    British Journal of Nutrition (2009) 101 :1846
  • Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects
    Tanja C. M. Adam and Margriet S. Westerterp-Plantenga
    British Journal of Nutrition (2005) 93 :845
  • Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1
    Jens Juul Holst
    Diabetes/Metabolism Research and Reviews (2002) 18 :430
  • Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells
    H. E. Parker, A. M. Habib, G. J. Rogers, F. M. Gribble, and F. Reimann
    Diabetologia (2009) 52 :289
  • The entero-insular axis: implications for human metabolism
    Lakshminarayan R. Ranganath
    Clinical Chemistry and Laboratory Medicine (2008) 46 :
  • The use of glycaemic index tables to predict glycaemic index of composite breakfast meals
    Anne Flint, Bente K. Møller, Anne Raben, Dorthe Pedersen, Inge Tetens, Jens J. Holst, and Arne Astrup
    British Journal of Nutrition (2004) 91 :979
  • The effects of two different hypocaloric diets on glucagon-like peptide 1 in obese adults, relation with insulin response after weight loss
    Daniel A. de Luis, Manuel Gonzalez Sagrado, Rosa Conde, Rocio Aller, and Olatz Izaola
    Journal of Diabetes and its Complications (2009) 23 :239
  • Gastric emptying of glucose solution and associated plasma concentrations of GLP-1, GIP, and PYY before and after fundoplication
    J. Miholic, M. Hoffmann, J.J. Holst, J. Lenglinger, M. Mittlböck, H. Bergmann, and G. Stacher
    Surgical Endoscopy (2007) 21 :309
  • Development of genetically engineered human intestinal cells for regulated insulin secretion using rAAV-mediated gene transfer
    Shiue-Cheng Tang and Athanassios Sambanis
    Biochemical and Biophysical Research Communications (2003) 303 :645
  • Glucagon-Like Peptide 1 Secretion by the L-Cell: The View From Within
    G. E. Lim and P. L. Brubaker
    Diabetes (2006) 55 :S70
  • GIP or not GIP? That is the question
    Timothy J Kieffer
    Trends in Pharmacological Sciences (2003) 24 :110
  • Chlorogenic acid differentially affects postprandial glucose and glucose-dependent insulinotropic polypeptide response in rats
    Jasmine M. Tunnicliffe, Lindsay K. Eller, Raylene A. Reimer, Dustin S. Hittel, and Jane Shearer
    Applied Physiology, Nutrition, and Metabolism (2011) 36 :650
  • Classification and functions of enteroendocrine cells of the lower gastrointestinal tract
    Ashok R. Gunawardene, Bernard M. Corfe, and Carolyn A. Staton
    International Journal of Experimental Pathology (2011) 92 :219
  • A Direct in Vivo Comparison of the Melanocortin Monovalent Agonist Ac-His-DPhe-Arg-Trp-NH2 versus the Bivalent Agonist Ac-His-DPhe-Arg-Trp-PEDG20-His-DPhe-Arg-Trp-NH2: A Bivalent Advantage
    Cody J. Lensing, Danielle N. Adank, Stacey L. Wilber, Katie T. Freeman, Sathya M. Schnell, Robert C. Speth, Adam T. Zarth, and Carrie Haskell-Luevano
    ACS Chemical Neuroscience (2017) :
  • Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction
    S. Delgado-Aros, A. Vella, M. Camilleri, P. A. Low, D. D. Burton, G. M. Thomforde, and D. Stephens
    Neurogastroenterology and Motility (2003) 15 :435
  • Protein digestion and energy homeostasis: How generated peptides may impact intestinal hormones?
    Juliette Caron, Dorothée Domenger, Yanath Belguesmia, Mostafa Kouach, Jean Lesage, Jean-François Goossens, Pascal Dhulster, Rozenn Ravallec, and Benoit Cudennec
    Food Research International (2016) 88 :310
  • Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential
    Jens Juul Holst
    Trends in Endocrinology & Metabolism (1999) 10 :229
  • Vesicular storage and secretion of l-glutamate from glucagon-like peptide 1-secreting clonal intestinal L cells
    Shunsuke Uehara, Sun-Kyung Jung, Riyo Morimoto, Shigeo Arioka, Takaaki Miyaji, Narinobu Juge, Miki Hiasa, Kahori Shimizu, Akinori Ishimura, Masato Otsuka, Akitsugu Yamamoto, Pierre Maechler, and Yoshinori Moriyama
    Journal of Neurochemistry (2006) 96 :550
  • Biology of Incretins: GLP-1 and GIP
    Laurie L. Baggio and Daniel J. Drucker
    Gastroenterology (2007) 132 :2131
  • Glucagon-Like Peptide-1 Receptor Agonist Administration Suppresses Both Water and Saline Intake in Rats
    N. J. McKay and D. Daniels
    Journal of Neuroendocrinology (2013) 25 :929
  • Absorption of glucagon-like peptide-1 can be protracted by zinc or protamine
    Lone Pridal, Hanne Agerbæk, Lone N. Christensen, Karina Thomsen, and Ole Kirk
    International Journal of Pharmaceutics (1996) 136 :53
  • Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite
    W. L. Hall, D. J. Millward, S. J. Long, and L. M. Morgan
    British Journal of Nutrition (2003) 89 :239
  • Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor
    Francis S. Willard and Kyle W. Sloop
    Experimental Diabetes Research (2012) 2012 :1
  • Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass
    Ding Xie, Qing Zhong, Ke-Hong Ding, Hua Cheng, Sandra Williams, Daniel Correa, Wendy B. Bollag, Roni J. Bollag, Karl Insogna, Nancy Troiano, Chistiane Coady, Mark Hamrick, and Carlos M. Isales
    Bone (2007) 40 :1352
  • Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis
    S.T. Ngo, F.J. Steyn, L. Huang, S. Mantovani, C.M.M. Pfluger, T.M. Woodruff, J.D. O'Sullivan, R.D. Henderson, and P.A. McCombe
    Journal of the Neurological Sciences (2015) 357 :22
  • Glucose-Sensing in Glucagon-Like Peptide-1-Secreting Cells
    F. Reimann and F. M. Gribble
    Diabetes (2002) 51 :2757
  • Identification and functional characterization of melatonin Mel 1a receptors in pancreatic β cells: potential role in incretin-mediated cell function by sensitization of cAMP signaling
    Daniel M Kemp, Mariano Ubeda, and Joel F Habener
    Molecular and Cellular Endocrinology (2002) 191 :157
  • Regulation of energy balance by a gut–brain axis and involvement of the gut microbiota
    Paige V. Bauer, Sophie C. Hamr, and Frank A. Duca
    Cellular and Molecular Life Sciences (2016) 73 :737
  • Comparison of sandwich enzyme-linked immunoadsorbent assay and radioimmunoassay for determination of exogenous glucagon-like peptide-1(7–36)amide in plasma
    Lone Pridal, Steen H. Ingwersen, Flemming S. Larsen, Jens J. Holst, Kim Adelhorst, and Ole Kirk
    Journal of Pharmaceutical and Biomedical Analysis (1995) 13 :841
  • Galanin is a potent inhibitor of glucagon-like peptide-1 secretion from rat ileum
    Christine Herrmann-Rinke, Dieter Hörsch, Gerard P. McGregor, and Burkhard Göke
    Peptides (1996) 17 :571
  • Proximate and Chemical Analysis of Gluten-free Enriched, Resistant Starch Type 3 from Maranta arundinacea Flour and its Potential as a Functional Food
    Mutiara Nugraheni, Badraningsih Lastariwat, and Sutriyati Purwanti
    Pakistan Journal of Nutrition (2017) 16 :322
  • The Melanocortin-4 Receptor Is Expressed in Enteroendocrine L Cells and Regulates the Release of Peptide YY and Glucagon-like Peptide 1 In Vivo
    Brandon L. Panaro, Iain R. Tough, Maja S. Engelstoft, Robert T. Matthews, Gregory J. Digby, Cathrine L. Møller, Berit Svendsen, Fiona Gribble, Frank Reimann, Jens J. Holst, Birgitte Holst, Thue W. Schwartz, Helen M. Cox, and Roger D. Cone
    Cell Metabolism (2014) 20 :1018
  • Beta Glucan: Health Benefits in Obesity and Metabolic Syndrome
    D. El Khoury, C. Cuda, B. L. Luhovyy, and G. H. Anderson
    Journal of Nutrition and Metabolism (2012) 2012 :1
  • Gastro-intestinal hormones GIP and GLP-1
    T.J. Kieffer
    Annales d'Endocrinologie (2004) 65 :13
  • Intestinal GLP-1 and satiation—from man to rodents and back
    R E Steinert, C Beglinger, and W Langhans
    International Journal of Obesity (2015) :
  • Effects of Selenium and Exendin-4 on Glucagon-Like Peptide-1 Receptor, IRS-1, and Raf-1 in the Liver of Diabetic Rats
    Ghinwa M. Barakat, Mohamed E. Moustafa, and Anwar B. Bikhazi
    Biochemical Genetics (2012) 50 :922
  • GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial
    Özlem Gögebakan, Martin A. Osterhoff, Rita Schüler, Olga Pivovarova, Michael Kruse, Anne-Cathrin Seltmann, Alexander S. Mosig, Natalia Rudovich, Michael Nauck, and Andreas F. H. Pfeiffer
    Diabetologia (2015) 58 :1759
  • Pancreatic β-cell signaling: toward better understanding of diabetes and its treatment
    Susumu SEINO, Tadao SHIBASAKI, and Kohtaro MINAMI
    Proceedings of the Japan Academy, Series B (2010) 86 :563
  • Gut peptides in the treatment of diabetes mellitus
    Torsten P Vahl and David A D’Alessio
    Expert Opinion on Investigational Drugs (2004) 13 :177
  • Oral delivery of therapeutic protein/peptide for diabetes – Future perspectives
    M.R. Rekha and Chandra P. Sharma
    International Journal of Pharmaceutics (2013) 440 :48
  • Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects
    M. D. Robertson, J. M. Currie, L. M. Morgan, D. P. Jewell, and K. N. Frayn
    Diabetologia (2003) 46 :659
  • Pharmacokinetics and Pharmacodynamics of Single Rising Intravenous Doses (0.5 mg–10 mg) and Determination of Absolute Bioavailability of the Dipeptidyl Peptidase-4 Inhibitor Linagliptin (BI 1356) in Healthy Male Subjects
    Silke Retlich, Vincent Duval, Arne Ring, Alexander Staab, Silke Hüttner, Arvid Jungnik, Ulrich Jaehde, Klaus A. Dugi, and Ulrike Graefe-Mody
    Clinical Pharmacokinetics (2010) 49 :829
  • Sympathetic pathways mediate GLP-1 actions in the gastrointestinal tract of the rat
    M. Giralt and P. Vergara
    Regulatory Peptides (1998) 74 :19
  • Lipids, CHOs, proteins: Can all macronutrients put a ‘brake’ on eating?
    H.S. Shin, J.R. Ingram, A.-T. McGill, and S.D. Poppitt
    Physiology & Behavior (2013) 120 :114
  • Physiological mechanisms mediating aspartame-induced satiety
    W.L. Hall, D.J. Millward, P.J. Rogers, and L.M. Morgan
    Physiology & Behavior (2003) 78 :557
  • A Radioimmunoassay for LY315902 an analog of Glucagon-like Insulinotropic Peptide, and Its Application in the Study of Canine Pharmacokinetics
    James Z. Chou, Gary D. Place, David G. Waters, Jeffrey A. Kirkwood, and Ronald R. Bowsher
    Journal of Pharmaceutical Sciences (1997) 86 :768
  • El GLP-1: acción biológica y posibles efectos terapéuticos
    I. Valverde, J. Cancelas, and M.L. Villanueva-Peñacarrillo
    Endocrinología y Nutrición (2006) 53 :256
  • Effects of GLP-1 on appetite and weight
    Meera Shah and Adrian Vella
    Reviews in Endocrine and Metabolic Disorders (2014) 15 :181
  • Effects of centrally-injected glucagon-like peptide-1 on pilocarpine-induced seizures, anxiety and locomotor and exploratory activity in rat
    Guldal Gulec, Naciye Isbil-Buyukcoskun, and Nevzat Kahveci
    Neuropeptides (2010) 44 :285
  • Gut chemosensing mechanisms
    Arianna Psichas, Frank Reimann, and Fiona M. Gribble
    Journal of Clinical Investigation (2015) 125 :908
  • Nutrient sensing in the gut: interactions between chemosensory cells, visceral afferents and the secretion of satiation peptides
    Robert E. Steinert and Christoph Beglinger
    Physiology & Behavior (2011) 105 :62
  • Different proteins and biopeptides differently affect satiety and anorexigenic/orexigenic hormones in healthy humans
    K Diepvens, D Häberer, and M Westerterp-Plantenga
    International Journal of Obesity (2008) 32 :510
  • Gastrointestinal peptides after bariatric surgery and appetite control: are they in tuning?
    Éric Doucet
    Current Opinion in Clinical Nutrition and Metabolic Care (2008) 11 :645
  • Phosphorus ingestion improves oral glucose tolerance of healthy male subjects: a crossover experiment
    May Khattab, Christelle Abi-Rashed, Hala Ghattas, Sani Hlais, and Omar Obeid
    Nutrition Journal (2015) 14 :
  • GPR40 (FFAR1) – Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo
    Maria Hauge, Marie A. Vestmar, Anna S. Husted, Jeppe P. Ekberg, Michael J. Wright, Jerry Di Salvo, Adam B. Weinglass, Maja S. Engelstoft, Andreas N. Madsen, Michael Lückmann, Michael W. Miller, Maria E. Trujillo, Thomas M. Frimurer, Birgitte Holst, Andrew D. Howard, and Thue W. Schwartz
    Molecular Metabolism (2015) 4 :3
  • Clinical Pharmacokinetics and Pharmacodynamics of Vildagliptin
    Yan-Ling He
    Clinical Pharmacokinetics (2012) 51 :147
  • Role of Gastrointestinal Hormones in Postprandial Reduction of Bone Resorption
    Dennis B Henriksen, Peter Alexandersen, Nina H Bjarnason, Tina Vilsbøll, Bolette Hartmann, Eva EG Henriksen, Inger Byrjalsen, Thure Krarup, Jens J Holst, and Claus Christiansen
    Journal of Bone and Mineral Research (2003) 18 :2180
  • Distinct Effects of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 on Insulin Secretion and Gut Motility
    T. Miki, K. Minami, H. Shinozaki, K. Matsumura, A. Saraya, H. Ikeda, Y. Yamada, J. J. Holst, and S. Seino
    Diabetes (2005) 54 :1056
  • The Effect of Extruded Orange Pulp on Enzymatic Hydrolysis of Starch and Glucose Retardation Index
    Miguel Angel Larrea Céspedes, Fernando Martínez Bustos, and Yoon Kil chang
    Food and Bioprocess Technology (2010) 3 :684
  • Efficient GLP-1 gene delivery using two-step transcription amplification plasmid system with a secretion signal peptide and arginine-grafted bioreducible polymer
    Tae-il Kim, Minhyung Lee, and Sung Wan Kim
    Journal of Controlled Release (2012) 157 :243
  • Ability of GLP-1 to decrease food intake is dependent on nutritional status
    Charlotte C. Ronveaux, Guillaume de Lartigue, and Helen E. Raybould
    Physiology & Behavior (2014) 135 :222
  • GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell
    L. M. Lauffer, R. Iakoubov, and P. L. Brubaker
    Diabetes (2009) 58 :1058
  • Possible role for apple juice phenolic compounds in the acute modification of glucose tolerance and gastrointestinal hormone secretion in humans
    Kelly L Johnston, Michael N Clifford, and Linda M Morgan
    Journal of the Science of Food and Agriculture (2002) 82 :1800
  • DPP4 inhibitors: from sitagliptin monotherapy to the new alogliptin-pioglitazone combination therapy
    Georgia Argyrakopoulou and John Doupis
    Advances in Therapy (2009) 26 :272
  • The environment within: how gut microbiota may influence metabolism and body composition
    A. Vrieze, F. Holleman, E. G. Zoetendal, W. M. de Vos, J. B. L. Hoekstra, and M. Nieuwdorp
    Diabetologia (2010) 53 :606
  • Secretion of the Incretin Hormones Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide Correlates with Insulin Secretion in Normal Man Throughout the Day
    C. Ørskov, A. Wettergren, and J. J. Holst
    Scandinavian Journal of Gastroenterology (1996) 31 :665
  • Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential?
    Victor A. Gault, Finbarr P.M. O’Harte, and Peter R. Flatt
    Neuropeptides (2003) 37 :253
  • Pancreatic regulation of glucose homeostasis
    Pia V Röder, Bingbing Wu, Yixian Liu, and Weiping Han
    Experimental & Molecular Medicine (2016) 48 :e219
  • Development of a cysteine-deprived and C-terminally truncated GLP-1 receptor
    Christina Rye Underwood, Lotte Bjerre Knudsen, Patrick W. Garibay, Günther H. Peters, and Steffen Reedtz-Runge
    Peptides (2013) 49 :100
  • Novel N-substituted-2-cyanopyrrolidines as potent inhibitors of dipeptidyl peptidase IV in the treatment of non-insulin-dependent diabetes mellitus
    Expert Opinion on Therapeutic Patents (2000) 10 :1937
  • GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects
    José C. Fernández-García, Mora Murri, Leticia Coin-Aragüez, Juan Alcaide, Rajaa El Bekay, and Francisco J. Tinahones
    Clinical Endocrinology (2014) 80 :671
  • Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach
    Florian Lippl, Florian Kircher, Johannes Erdmann, Hans-Dieter Allescher, and Volker Schusdziarra
    Regulatory Peptides (2004) 119 :93
  • Imaging exocytosis of single glucagon-like peptide-1 containing granules in a murine enteroendocrine cell line with total internal reflection fluorescent microscopy
    Mica Ohara-Imaizumi, Kyota Aoyagi, Yoshihiro Akimoto, Yoko Nakamichi, Chiyono Nishiwaki, Hayato Kawakami, and Shinya Nagamatsu
    Biochemical and Biophysical Research Communications (2009) 390 :16
  • Expression of Na+/glucose co-transporter 1 (SGLT1) is enhanced by supplementation of the diet of weaning piglets with artificial sweeteners
    Andrew W. Moran, Miran A. Al-Rammahi, Daleep K. Arora, Daniel J. Batchelor, Erin A. Coulter, Kristian Daly, Catherine Ionescu, David Bravo, and Soraya P. Shirazi-Beechey
    British Journal of Nutrition (2010) 104 :637
  • Oral Delivery of Glucagon Like Peptide-1 by a Recombinant Lactococcus lactis
    Payal Agarwal, Pulkit Khatri, Blasé Billack, Woon-Kai Low, and Jun Shao
    Pharmaceutical Research (2014) 31 :3404
  • New treatments for type 2 diabetes mellitus: combined therapy with sitagliptin
    Juan José Gagliardino, Silvina Santoro, Sara Arellano, and Guillermo Di Girolamo
    Expert Opinion on Pharmacotherapy (2008) 9 :1495
  • Effect of glucagon on carbohydrate-mediated secretion of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-36 amide) (GLP-1)
    L. Ranganath, F. Schaper, R. Gama, L. Morgan, J. Wright, D. Teale, and V. Marks
    Diabetes/Metabolism Research and Reviews (1999) 15 :390
  • Role of Leptin in the Regulation of Glucagon-Like Peptide-1 Secretion
    Y. Anini and P. L. Brubaker
    Diabetes (2003) 52 :252
  • Matching Meals to Body Clocks—Impact on Weight and Glucose Metabolism
    Amy Hutchison, Gary Wittert, and Leonie Heilbronn
    Nutrients (2017) 9 :222
  • Liraglutide counteracts obesity and glucose intolerance in a mouse model of glucocorticoid-induced metabolic syndrome
    Liselotte Fransson, Cristiane dos Santos, Petra Wolbert, Åke Sjöholm, Alex Rafacho, and Henrik Ortsäter
    Diabetology & Metabolic Syndrome (2014) 6 :3
  • Control of Food Intake by Gastrointestinal Peptides: Mechanisms of Action and Possible Modulation in the Treatment of Obesity
    Philip Prinz and Andreas Stengel
    Journal of Neurogastroenterology and Motility (2017) 23 :180
  • A randomized, double-blind, placebo-controlled, multiple-dose, parallel-group clinical trial to assess the effects of teduglutide on gastric emptying of liquids in healthy subjects
    Jolene Kay Berg, Eric H Kim, Benjamin Li, Bo Joelsson, and Nader N Youssef
    BMC Gastroenterology (2014) 14 :
  • Glucose intolerance caused by a defect in the entero-insular axis: A study in gastric inhibitory polypeptide receptor knockout mice
    K. Miyawaki, Y. Yamada, H. Yano, H. Niwa, N. Ban, Y. Ihara, A. Kubota, S. Fujimoto, M. Kajikawa, A. Kuroe, K. Tsuda, H. Hashimoto, T. Yamashita, T. Jomori, F. Tashiro, J.-i. Miyazaki, and Y. Seino
    Proceedings of the National Academy of Sciences (1999) 96 :14843
  • Preliminary report Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7–36)NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake
    A.A. Young, B.R. Gedulin, and T.J. Rink
    Metabolism (1996) 45 :1
  • Orlistat Augments Postprandial Increases in Glucagon-like Peptide 1 in Obese Type 2 Diabetic Patients
    T. Damci, S. Yalin, H. Balci, Z. Osar, U. Korugan, M. Ozyazar, and H. Ilkova
    Diabetes Care (2004) 27 :1077
  • Ezetimibe Stimulates Intestinal Glucagon-Like Peptide 1 Secretion Via the MEK/ERK Pathway Rather Than Dipeptidyl Peptidase 4 Inhibition
    Eugene Chang, Lisa Kim, Jung Mook Choi, Se Eun Park, Eun-Jung Rhee, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Dong Il Park, and Cheol-Young Park
    Metabolism (2015) 64 :633
  • Glucagon-Like Peptide-1 7-36 Amide and Peptide YY Have Additive Inhibitory Effect on Gastric Acid Secretion in Man
    A. Wettergren, P. Maina, S. Boesby, and J. J. Holst
    Scandinavian Journal of Gastroenterology (1997) 32 :552
  • Increased secretion of insulin and proliferation of islet β-cells in rats with mesenteric lymph duct ligation
    Ko Nagino, Junji Yokozawa, Yu Sasaki, Akiko Matsuda, Hiroaki Takeda, and Sumio Kawata
    Biochemical and Biophysical Research Communications (2012) 425 :266
  • Glucagon-like Peptide-1 Plasmid Construction and Delivery for the Treatment of Type 2 Diabetes
    Suna Choi, Seungjoon Oh, Minhyung Lee, and Sung Wan Kim
    Molecular Therapy (2005) 12 :885
  • Expression and purification of exendin-4, a GLP-1 receptor agonist, in Escherichia coli
    Xiaopu Yin, Dongzhi Wei, Lina Yi, Xinyi Tao, and Yushu Ma
    Protein Expression and Purification (2005) 41 :259
  • The value of short- and long-acting glucagon-like peptide-1 agonists in the management of type 2 diabetes mellitus: experience with exenatide
    Xiao-Hui Guo
    Current Medical Research and Opinion (2016) 32 :61
  • Effects of the novel (Pro3)GIP antagonist and exendin(9–39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin
    V. A. Gault, F. P. M. O'Harte, P. Harriott, M. H. Mooney, B. D. Green, and P. R. Flatt
    Diabetologia (2003) 46 :222
  • The effects of cereal source and processing on the metabolic responses to commercially available breakfast cereals and breads
    R. M. Elliott, L. M. Morgan, J. A. Tredger, and J. Wright
    International Journal of Food Sciences and Nutrition (1994) 45 :217
  • Bile Acid Sequestration Reduces Plasma Glucose Levels in db/db Mice by Increasing Its Metabolic Clearance Rate
    Maxi Meissner, Hilde Herrema, Theo H. van Dijk, Albert Gerding, Rick Havinga, Theo Boer, Michael Müller, Dirk-Jan. Reijngoud, Albert K. Groen, Folkert Kuipers, and Irina Agoulnik
    PLoS ONE (2011) 6 :e24564
  • Changes in Gastrointestinal Hormone Responses, Insulin Sensitivity, and Beta-Cell Function Within 2 Weeks After Gastric Bypass in Non-diabetic Subjects
    S. H. Jacobsen, S. C. Olesen, C. Dirksen, N. B. Jørgensen, K. N. Bojsen-Møller, U. Kielgast, D. Worm, T. Almdal, L. S. Naver, L. E. Hvolris, J. F. Rehfeld, B. S. Wulff, T. R. Clausen, D. L. Hansen, J. J. Holst, and S. Madsbad
    Obesity Surgery (2012) 22 :1084
  • Gastrointestinal satiety signals in humans — Physiologic roles for GLP-1 and PYY ?
    Christoph Beglinger and Lukas Degen
    Physiology & Behavior (2006) 89 :460
  • Diurnal rhythms of plasma GLP-1 levels in normal and overweight/obese subjects: lack of effect of weight loss
    Joaquín Santiago Galindo Muñoz, Diana Jiménez Rodríguez, and Juan José Hernández Morante
    Journal of Physiology and Biochemistry (2015) 71 :17
  • Plasticity of gastro-intestinal vagal afferent endings
    Stephen J. Kentish and Amanda J. Page
    Physiology & Behavior (2014) 136 :170
  • Feeding an Elemental Diet vs a Milk-Based Formula Does Not Decrease Intestinal Mucosal Growth in Infant Pigs
    Barbara Stoll, Pamela T. Price, Peter J. Reeds, Xiaoyan Chang, Josef F. Henry, Johannes B. van Goudoever, Jens J. Holst, and Douglas G. Burrin
    Journal of Parenteral and Enteral Nutrition (2006) 30 :32
  • The endocrine disrupting potential of monosodium glutamate (MSG) on secretion of the glucagon-like peptide-1 (GLP-1) gut hormone and GLP-1 receptor interaction
    Maeve Shannon, Brian Green, Gary Willars, Jodie Wilson, Natalie Matthews, Joanna Lamb, Anna Gillespie, and Lisa Connolly
    Toxicology Letters (2017) 265 :97
  • Glucose sensing and signalling; regulation of intestinal glucose transport
    S. P. Shirazi-Beechey, A. W. Moran, D. J. Batchelor, K. Daly, and M. Al-Rammahi
    Proceedings of the Nutrition Society (2011) 70 :185
  • Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes
    M. Hiroyoshi, K. Tateishi, Y. Yasunami, K. Maeshiro, J. Ono, Y. Matsuoka, and S. Ikeda
    The American Journal of Gastroenterology (1999) 94 :976
  • The Inhibitory Effect of Glucagon-Like Peptide-1 (7-36)amide on Antral Motility is Antagonized by Its N-Terminally Truncated Primary Metabolite GLP-1 (9-36)amide
    A. Wettergren, M. Wøjdemann, and J.J. Holst
    Peptides (1998) 19 :877
  • Mechanisms and effects of “fat taste” in humans
    Robin M. Tucker, Richard D. Mattes, and Cordelia A. Running
    BioFactors (2014) 40 :313
  • Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats
    Yongho Lee, Mi Kyong Kwon, Eun Seok Kang, Young Mi Park, Seung Ho Choi, Chul Woo Ahn, Kyung Sub Kim, Chul Won Park, Bong Soo Cha, Sung Wan Kim, Je Kyung Sung, Eun Jig Lee, and Hyun Chul Lee
    The Journal of Gene Medicine (2008) 10 :260
  • Evidence for the Gut Microbiota Short-Chain Fatty Acids as Key Pathophysiological Molecules Improving Diabetes
    Alessandra Puddu, Roberta Sanguineti, Fabrizio Montecucco, and Giorgio Luciano Viviani
    Mediators of Inflammation (2014) 2014 :1
  • Nutrients related to GLP1 secretory responses
    Asieh Mansour, Saeed Hosseini, Bagher Larijani, Mohamad Pajouhi, and Mohammad Reza Mohajeri-Tehrani
    Nutrition (2013) 29 :813
  • MECHANISMS IN ENDOCRINOLOGY: Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion
    D. P. Sonne, M. Hansen, and F. K. Knop
    European Journal of Endocrinology (2014) 171 :R47
  • A Novel Glucose-Sensing Mechanism Contributing to Glucagon-Like Peptide-1 Secretion From the GLUTag Cell Line
    F. M. Gribble, L. Williams, A. K. Simpson, and F. Reimann
    Diabetes (2003) 52 :1147
  • Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum
    Lene Hansen, Bolette Hartmann, Hitoshi Mineo, and Jens J. Holst
    Regulatory Peptides (2004) 118 :11
  • Lack of Effects of a Single High-Fat Meal Enriched with Vegetable n-3 or a Combination of Vegetable and Marine n-3 Fatty Acids on Intestinal Peptide Release and Adipokines in Healthy Female Subjects
    Ingunn Narverud, Mari C. W. Myhrstad, Karl-Heinz Herzig, Toni Karhu, Tuva B. Dahl, Bente Halvorsen, Stine M. Ulven, and Kirsten B. Holven
    Frontiers in Nutrition (2016) 3 :
  • Structural requirements of the N-terminal region of GLP-1-[7-37]-NH2 for receptor interaction and cAMP production
    Cyril Sarrauste de Menthière, Alain Chavanieu, Gérard Grassy, Stéphane Dalle, Guillermo Salazar, Alain Kervran, Bruno Pfeiffer, Pierre Renard, Philippe Delagrange, Dominique Manechez, David Bakes, Alain Ktorza, and Bernard Calas
    European Journal of Medicinal Chemistry (2004) 39 :473
  • Impact of early versus late enteral nutrition on cell mediated immunity and its relationship with glucagon like peptide-1 in intensive care unit patients: a prospective study
    Okan Bakiner, Emre Bozkirli, Semih Giray, Zulfikar Arlier, Ilknur Kozanoglu, Nurzen Sezgin, Cagla Sariturk, and Eda Ertorer
    Critical Care (2013) 17 :R123
  • Enhancing Incretin Action for the Treatment of Type 2 Diabetes
    D. J. Drucker
    Diabetes Care (2003) 26 :2929
  • Incretin hormone receptors are required for normal beta cell development and function in female mice
    Bilal Omar, Linda Ahlkvist, Yuchiro Yamada, Yutaka Seino, and Bo Ahrén
    Peptides (2016) 79 :58
  • Signaling Mechanisms Underlying the Release of Glucagon-Like Peptide 1
    F. Reimann, P. S. Ward, and F. M. Gribble
    Diabetes (2006) 55 :S78
  • Modulating GPR40: therapeutic promise and potential in diabetes
    Vincent Poitout and Daniel C.-H. Lin
    Drug Discovery Today (2013) 18 :1301
  • Inhibition of human gastric lipase by intraduodenal fat involves glucagon-like peptide-1 and cholecystokinin
    Morten Wøjdemann, Claus Riber, Thue Bisgaard, Berit Sternby, Steen Larsen, Jens F Rehfeld, Jens J Holst, and Ole Olsen
    Regulatory Peptides (1999) 80 :101
  • Insulin-Producing Intestinal K Cells Protect Nonobese Diabetic Mice From Autoimmune Diabetes
    Majid Mojibian, Ada W.Y. Lam, Yukihiro Fujita, Ali Asadi, Guntram A. Grassl, Peter Dickie, Rusung Tan, Anthony T. Cheung, and Timothy J. Kieffer
    Gastroenterology (2014) 147 :162
  • Effect of hormone therapy on the enteroinsular axis
    Krystyna Sztefko, Iwona Rogatko, Tomasz Milewicz, Józef Krzysiek, Przemyslaw J Tomasik, and Zdzislaw Szafran
    Menopause (2005) 12 :630
  • Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic system and vasopressin
    Naciye Isbil-Buyukcoskun and Guldal Gulec
    Regulatory Peptides (2004) 118 :33
  • Influences of protein ingestion on glucagon-like peptide (GLP)-1-immunoreactive endocrine cells in the chicken ileum
    Mohammad M. Monir, Kohzy Hiramatsu, Sachiko Matsumoto, Kei Nishimura, Chihiro Takemoto, Tomomi Shioji, Takafumi Watanabe, Kazumi Kita, Shinichi Yonekura, and Sang Gun Roh
    Animal Science Journal (2014) 85 :581
  • An Emerging Role of Glucagon-Like Peptide-1 in Preventing Advanced-Glycation-End-Product-Mediated Damages in Diabetes
    Alessandra Puddu, François Mach, Alessio Nencioni, Giorgio Luciano Viviani, and Fabrizio Montecucco
    Mediators of Inflammation (2013) 2013 :1
  • Enhanced glucose‐dependent glucagon‐like peptide‐1 and insulin secretion in Crohn patients with terminal ileum disease is unrelated to disease activity or ileal resection
    N. Bendet, E. Scapa, O. Cohen, O. Bloch, D. Aharoni, Y. Ramot, M. Weiss, A. Halevi, and M. J. Rapoport
    Scandinavian Journal of Gastroenterology (2004) 39 :650
  • Incretin Mimetics as Emerging Treatments for Type 2 Diabetes
    Scott V Joy, Philip T Rodgers, and Ann C Scates
    Annals of Pharmacotherapy (2005) 39 :110
  • The Influence of Restricted Feeding on Glucagon-Like Peptide-1 (GLP-1)-Containing Cells in the Chicken Small Intestine
    M. M. Monir, K. Hiramatsu, A. Yamasaki, K. Nishimura, and T. Watanabe
    Anatomia, Histologia, Embryologia (2014) 43 :153
  • Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes
    T. Forst, B. Uhlig-Laske, A. Ring, U. Graefe-Mody, C. Friedrich, K. Herbach, H.-J. Woerle, and K. A. Dugi
    Diabetic Medicine (2010) 27 :1409
  • Incretin-based therapies: mimetics versus protease inhibitors
    Patricia L. Brubaker
    Trends in Endocrinology & Metabolism (2007) 18 :240
  • Glucagon-like peptide-1: The missing link in the metabolic clock?
    Patricia L Brubaker and Manuel Gil-Lozano
    Journal of Diabetes Investigation (2016) 7 :70
  • Pharmacology and physiology of gastrointestinal enteroendocrine cells
    O. J. Mace, B. Tehan, and F. Marshall
    Pharmacology Research & Perspectives (2015) 3 :e00155
  • Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus
    Jens Juul Holst and Maria A. McGill
    Clinical Drug Investigation (2012) 32 :1
  • Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential
    S. S. Torekov, S. Madsbad, and J. J. Holst
    Obesity Reviews (2011) 12 :593
  • Appetite control after weight loss: what is the role of bloodborne peptides?
    Éric Doucet and Jameason Cameron
    Applied Physiology, Nutrition, and Metabolism (2007) 32 :523
  • The Effect of Nopal (Opuntia Ficus Indica) on Postprandial Blood Glucose, Incretins, and Antioxidant Activity in Mexican Patients with Type 2 Diabetes after Consumption of Two Different Composition Breakfasts
    Patricia López-Romero, Edgar Pichardo-Ontiveros, Azalia Avila-Nava, Natalia Vázquez-Manjarrez, Armando R. Tovar, José Pedraza-Chaverri, and Nimbe Torres
    Journal of the Academy of Nutrition and Dietetics (2014) 114 :1811
  • Xenin, a Gastrointestinal Peptide, Regulates Feeding Independent of the Melanocortin Signaling Pathway
    A. Leckstrom, E. R. Kim, D. Wong, and T. M. Mizuno
    Diabetes (2009) 58 :87
  • Metabolic impact of a successful lifestyle intervention in patients with new onset type 2 diabetes; a pilot study
    Joe Begley, Antia Bowes, Tanya Hart, Soha Zouwail, and David Kerr
    Journal of Diabetes Research and Clinical Metabolism (2013) 2 :10
  • Probing the diurnal regulation of glycemic control
    Shelagh M. Hampton and Jonathan D. Johnston
    Journal of Diabetes and its Complications (2014) 28 :751
  • Colestimide Lowers Plasma Glucose Levels and Increases Plasma Glucagon-like Peptide-1 (7-36) Levels in Patients with Type 2 Diabetes Mellitus Complicated by Hypercholesterolemia
    Tatsuya Suzuki, Kenzo Oba, Yoshimasa Igari, Noriaki Matsumura, Kentaro Watanabe, Shoko Futami-Suda, Hiroko Yasuoka, Motoshi Ouchi, Kazunari Suzuki, Yoshiaki Kigawa, and Hiroshi Nakano
    Journal of Nippon Medical School (2007) 74 :338
  • Evaluation of glycated glucagon-like peptide-1(7-36)amide in intestinal tissue of normal and diabetic animal models
    Mark H Mooney, Yasser H.A Abdel-Wahab, Aine M McKillop, Finbarr P.M O’Harte, and Peter R Flatt
    Biochimica et Biophysica Acta (BBA) - General Subjects (2002) 1569 :75
  • GLP-1. Generalidades e interacción incretinas-nutrientes
    M. de La Higuera López-Frías, S. Valdés Hernández, and F. Soriguer Escofet
    Revista Clínica Española (2007) 207 :501
  • Molecular mechanisms underlying nutrient-stimulated incretin secretion
    Helen E. Parker, Frank Reimann, and Fiona M. Gribble
    Expert Reviews in Molecular Medicine (2010) 12 :
  • Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System
    Jonathan Janssens, Harmonie Etienne, Sherif Idriss, Abdelkrim Azmi, Bronwen Martin, and Stuart Maudsley
    Frontiers in Endocrinology (2014) 5 :
  • Incretin hormones and beta-cell mass expansion: what we know and what is missing?
    Federica Tortosa and Francesco Dotta
    Archives of Physiology and Biochemistry (2013) 119 :161
  • Identification of amidated forms of GLP-1 in rat tissues using a highly sensitive radioimmunoassay
    Jozef van Delft, L.O Uttenthal, O.G Hermida, Tomás Fontela, and Margarita Ghiglione
    Regulatory Peptides (1997) 70 :191
  • Novel Molecules Regulating Energy Homeostasis: Physiology and Regulation by Macronutrient Intake and Weight Loss
    Anna Gavrieli and Christos S. Mantzoros
    Endocrinology and Metabolism (2016) 31 :361
  • Free fatty acids administered into the colon promote the secretion of glucagon-like peptide-1 and insulin
    Tetsuya Adachi, Toshiki Tanaka, Kazuhisa Takemoto, Taka-aki Koshimizu, Akira Hirasawa, and Gozoh Tsujimoto
    Biochemical and Biophysical Research Communications (2006) 340 :332
  • Effect of dietary macronutrients on postprandial incretin hormone release and satiety in obese and normal-weight women
    Tomasz Wikarek, Jerzy Chudek, Aleksander Owczarek, and Magdalena Olszanecka-Glinianowicz
    British Journal of Nutrition (2014) 111 :236
  • Nutritional influences on gut hormone release
    Gary Frost, Audrey E Brynes, Sandra Ellis, Joanne E Milton, Mohsen Nematy, and Elena Philippou
    Current Opinion in Endocrinology & Diabetes (2006) 13 :42
  • Peripheral Signals Mediate the Beneficial Effects of Gastric Surgery in Obesity
    Silvia Barja-Fernández, Cintia Folgueira, Cecilia Castelao, Rosaura Leis, Felipe F. Casanueva, and Luisa M. Seoane
    Gastroenterology Research and Practice (2015) 2015 :1
  • A novel long-acting glucose-dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents
    K. Tatarkiewicz, D. M. Hargrove, C. M. Jodka, B. R. Gedulin, P. A. Smith, J. A. Hoyt, A. Lwin, L. Collins, L. Mamedova, O. E. Levy, L. D'Souza, S. Janssen, V. Srivastava, S. S. Ghosh, and D. G. Parkes
    Diabetes, Obesity and Metabolism (2014) 16 :75
  • Targeting the TGR5-GLP-1 pathway to combat type 2 diabetes and non-alcoholic fatty liver disease
    T.W. H. Pols, J. Auwerx, and K. Schoonjans
    Gastroentérologie Clinique et Biologique (2010) 34 :270
  • GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome
    p. m. hellström, e. näslund, t. edholm, p. t. schmidt, j. kristensen, e. theodorsson, j. j. holst, and s. efendic
    Neurogastroenterology & Motility (2008) 20 :649
  • Responses in gut hormones and hunger to diets with either high protein or a mixture of protein plus free amino acids supplied under weight-loss conditions
    Gerald E. Lobley, Grietje Holtrop, Graham W. Horgan, David M. Bremner, Claire Fyfe, and Alexandra M. Johnstone
    British Journal of Nutrition (2015) 113 :1254
  • Gut peptides and the regulation of appetite
    M. S. B. Huda, J. P. H. Wilding, and J. H. Pinkney
    Obesity Reviews (2006) 7 :163
  • Individually timing high-protein preloads has no effect on daily energy intake, peptide YY and glucagon-like peptide-1
    S M Willbond and É Doucet
    European Journal of Clinical Nutrition (2011) 65 :55
  • Impact of postprandial glycaemia on health and prevention of disease
    E. E. Blaak, J.-M. Antoine, D. Benton, I. Björck, L. Bozzetto, F. Brouns, M. Diamant, L. Dye, T. Hulshof, J. J. Holst, D. J. Lamport, M. Laville, C. L. Lawton, A. Meheust, A. Nilson, S. Normand, A. A. Rivellese, S. Theis, S. S. Torekov, and S. Vinoy
    Obesity Reviews (2012) 13 :923
  • Glucagon-like peptides 1 and 2
    Hannelouise Kissow
    Current Opinion in Supportive and Palliative Care (2015) 9 :196
  • Increased plasma levels of glucose-dependent insulinotropic polypeptide are associated with decreased postprandial energy expenditure after modern Japanese meals
    Noriko Osaki, Chika Suzukamo, Kouji Onizawa, Tadashi Hase, and Akira Shimotoyodome
    European Journal of Nutrition (2016) :
  • Enteral supplementation with glutamine, fiber, and oligosaccharide modulates incretin and glucagon-like peptide-2 secretion
    Erina Joo, Atsushi Muraoka, Akihiro Hamasaki, Norio Harada, Shunsuke Yamane, Yaeko Kondo, Kazuyo Suzuki, Daniela Nasteska, Kimitaka Shibue, Takanari Harada, Kanako Iwasaki, Hidemi Tsuji, Kenichiro Shide, and Nobuya Inagaki
    Journal of Diabetes Investigation (2015) 6 :302
  • Insulin secretion in healthy subjects and patients with Type 2 diabetes – role of the gastrointestinal tract
    Jing Ma, Christopher K. Rayner, Karen L. Jones, and Michael Horowitz
    Best Practice & Research Clinical Endocrinology & Metabolism (2009) 23 :413
  • Targeting postprandial hyperglycemia
    Marc S. Rendell and Lois Jovanovic
    Metabolism (2006) 55 :1263
  • Nutritional regulation of glucagon-like peptide-1 secretion
    Gwen Tolhurst, Frank Reimann, and Fiona M. Gribble
    The Journal of Physiology (2009) 587 :27
  • Glucose-dependent insulinotropic polypeptide (GIP) and the enteroinsular axis in equines (Equus caballus)
    R Dühlmeier, E Deegen, H Fuhrmann, A Widdel, and H.-P Sallmann
    Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology (2001) 129 :563
  • Update on incretin hormones
    Liza K. Phillips and Johannes B. Prins
    Annals of the New York Academy of Sciences (2011) 1243 :E55
  • GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice
    Tanya Hansotia and Daniel J. Drucker
    Regulatory Peptides (2005) 128 :125
  • Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity
    Giuseppina Opinto, Annalisa Natalicchio, and Piero Marchetti
    Archives of Physiology and Biochemistry (2013) 119 :170
  • Glucagon-like peptide 2: an update
    Eric D Shin, Daniel J Drucker, and Patricia L Brubaker
    Current Opinion in Endocrinology & Diabetes (2005) 12 :63
  • GIF biology and fat metabolism
    Rupert G.C. Yip and M.Michael Wolfe
    Life Sciences (1999) 66 :91
  • The role of food intake regulating peptides in cardiovascular regulation
    B. Mikulášková, L. Maletínská, J. Zicha, and J. Kuneš
    Molecular and Cellular Endocrinology (2016) 436 :78
  • Free fatty acid receptor 2 and nutrient sensing: a proposed role for fibre, fermentable carbohydrates and short-chain fatty acids in appetite regulation
    Michelle L. Sleeth, Emily L. Thompson, Heather E. Ford, Sagen E. K. Zac-Varghese, and Gary Frost
    Nutrition Research Reviews (2010) 23 :135
  • A novel GLP-1 analog, BPI3006, with potent DPP IV resistance and good glucoregulatory effect
    Caina Li, Yi Huan, Ning Shen, Lixia Ji, Sujuan Sun, Shuainan Liu, Quan Liu, Lihui Gao, Fenlai Tan, Yanping Wang, and Zhufang Shen
    Biochemical and Biophysical Research Communications (2010) 400 :563
  • Pulmonary delivery of a GLP-1 receptor agonist, BMS-686117
    Feng Qian, Neil Mathias, Paul Moench, Cecilia Chi, Sridhar Desikan, Munir Hussain, and Ronald L. Smith
    International Journal of Pharmaceutics (2009) 366 :218
  • Nutrient-induced secretion and metabolic effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1
    J. M. E. Knapper, L. M. Morgan, and J. M. Fletcher
    Proceedings of the Nutrition Society (1996) 55 :291
  • Electrical activity-triggered glucagon-like peptide-1 secretion from primary murine L-cells
    G. J. Rogers, G. Tolhurst, A. Ramzan, A. M. Habib, H. E. Parker, F. M. Gribble, and F. Reimann
    The Journal of Physiology (2011) 589 :1081
  • Association between coefficients of variation of the R-R intervals on electrocardiograms and post-challenge hyperglycemia in patients with newly diagnosed type 2 diabetes
    Yusuke Nakade, Toshinari Takamura, Masaru Sakurai, Hirofumi Misu, Mitsuko Nagata, Yuko Nanbu, Hiroyasu Oe, Toshiji Takamura, Yoshio Sakai, Shuichi Kaneko, and Takashi Wada
    Journal of Diabetes Investigation (2011) 2 :324
  • Glucagon-like peptide-1 protects the murine hippocampus against stressors via Akt and ERK1/2 signaling
    Yuta Yoshino, Mitsue Ishisaka, Saori Tsujii, Masamitsu Shimazawa, and Hideaki Hara
    Biochemical and Biophysical Research Communications (2015) 458 :274
  • Energy intake and obesity: Ingestive frequency outweighs portion size
    Richard Mattes
    Physiology & Behavior (2014) 134 :110
  • What do we know about the secretion and degradation of incretin hormones?
    Carolyn F. Deacon
    Regulatory Peptides (2005) 128 :117
  • Integration of Satiety Signals by the Central Nervous System
    Adam P. Chambers, Darleen A. Sandoval, and Randy J. Seeley
    Current Biology (2013) 23 :R379
  • Glucose transporters are expressed in taste receptor cells
    Flavia Merigo, Donatella Benati, Mirko Cristofoletti, Francesco Osculati, and Andrea Sbarbati
    Journal of Anatomy (2011) 219 :243
  • Effects of glucose-dependent insulinotropic polypeptide on glucagon
    Mikkel Christensen and Filip K. Knop
    Cardiovascular Endocrinology (2016) 5 :75
  • Acute Effect on Satiety, Resting Energy Expenditure, Respiratory Quotient, Glucagon-Like Peptide-1, Free Fatty Acids, and Glycerol Following Consumption of a Combination of Bioactive Food Ingredients in Overweight Subjects
    Mariangela Rondanelli, Annalisa Opizzi, Simone Perna, Milena Faliva, Sebastiano Bruno Solerte, Marisa Fioravanti, Catherine Klersy, Cava Edda, Paolini Maddalena, Scavone Luciano, Ceccarelli Paola, Castellaneta Emanuela, Savina Claudia, and Lorenzo Maria Donini
    Journal of the American College of Nutrition (2013) 32 :41
  • Dynamics of insulin secretion and the clinical implications for obesity and diabetes
    Susumu Seino, Tadao Shibasaki, and Kohtaro Minami
    Journal of Clinical Investigation (2011) 121 :2118
  • The effect of ileal interposition surgery on enteroendocrine cell numbers in the UC Davis type 2 diabetes mellitus rat
    Carl Frederik Hansen, Efstathios Vassiliadis, Niels Vrang, Per T. Sangild, Bethany P. Cummings, Peter Havel, and Jacob Jelsing
    Regulatory Peptides (2014) 189 :31
  • Gut hormones as pharmaceuticals
    Jens Juul Holst
    Regulatory Peptides (2000) 93 :45
  • Glucagon-Like Peptide-1 Gene Therapy
    Anne M. Rowzee, Niamh X. Cawley, John A. Chiorini, and Giovanni Di Pasquale
    Experimental Diabetes Research (2011) 2011 :1
  • Synthesis and secretion of glucagon-like peptide-1 by fetal rat intestinal cells in culture
    T. H. Jackson Huang and Patricia L. Brubaker
    Endocrine (1995) 3 :499
  • Incretins: new targets for the prevention of diabetes and obesity
    Karl J Neff and Carel W le Roux
    Clinical Lipidology (2013) 8 :109
  • Calcitonin gene-related peptide potently stimulates glucagon-like peptide-1 release in the isolated perfused rat ileum
    C Herrmann–Rinke, G.P McGregor, and B Göke
    Peptides (2000) 21 :431
  • Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects
    R.J Bollag, Q Zhong, K.H Ding, P Phillips, L Zhong, F Qin, J Cranford, A.L Mulloy, R Cameron, and C.M Isales
    Molecular and Cellular Endocrinology (2001) 177 :35
  • Characterization of the Cellular and Metabolic Effects of a Novel Enzyme-Resistant Antagonist of Glucose-Dependent Insulinotropic Polypeptide
    Victor A. Gault, Finbarr P.M. O'Harte, Patrick Harriott, and Peter R. Flatt
    Biochemical and Biophysical Research Communications (2002) 290 :1420
  • Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?
    David J Grieve, Roslyn S Cassidy, and Brian D Green
    British Journal of Pharmacology (2009) 157 :1340
  • Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans
    L.J. Karhunen, K.R. Juvonen, A. Huotari, A.K. Purhonen, and K.H. Herzig
    Regulatory Peptides (2008) 149 :70
  • Roles of cAMP signalling in insulin granule exocytosis
    S. Seino, H. Takahashi, W. Fujimoto, and T. Shibasaki
    Diabetes, Obesity and Metabolism (2009) 11 :180
  • Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function
    Chinmay S. Marathe, Christopher K. Rayner, Karen L. Jones, and Michael Horowitz
    Experimental Diabetes Research (2011) 2011 :1